PET/MRI in Neuroendocrine Tumours
作者： Simon Wan , Jamshed Bomanji
DOI: 10.1007/978-3-319-68517-5_16
关键词:
摘要: Hybrid PET/MRI scanners allowing whole-body imaging are now available for clinical and research use. This new technology has the potential to combine exquisite sensitivity molecular relevance of PET imaging, spatial resolution soft tissue contrast MRI functional capability both, achieve a synergistic effect. The study its impact on NET management is still at infancy. However, in this setting can be gained from our experience with existing radiopharmaceuticals, comparative PET/CT contrasting their relative merits studies date topic.
springer.com
sci-hub.se 参考文章(37)
David S. Klimstra, Himisha Beltran, Rogerio Lilenbaum, Emily Bergsland, The spectrum of neuroendocrine tumors: histologic classification, unique features and areas of overlap. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. ,vol. 35, pp. 92- 103 ,(2015) , 10.14694/EDBOOK_AM.2015.35.92
C. Schraml, N. F. Schwenzer, O. Sperling, P. Aschoff, M. P. Lichy, M. Muller, C. Brendle, M. K. Werner, C. D. Claussen, C. Pfannenberg, Staging of neuroendocrine tumours: comparison of [⁶⁸Ga]DOTATOC multiphase PET/CT and whole-body MRI. Cancer Imaging. ,vol. 13, pp. 63- 72 ,(2013) , 10.1102/1470-7330.2013.0007
Nils F. Schreiter, Munenobu Nogami, Ingo Steffen, Ulrich-Frank Pape, Bernd Hamm, Winfried Brenner, Rainer Röttgen, Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours European Radiology. ,vol. 22, pp. 458- 467 ,(2012) , 10.1007/S00330-011-2266-4
Alejandro Sanchez-Crespo, Comparison of Gallium-68 and Fluorine-18 imaging characteristics in positron emission tomography. Applied Radiation and Isotopes. ,vol. 76, pp. 55- 62 ,(2013) , 10.1016/J.APRADISO.2012.06.034
Juri Ruf, Jan Schiefer, Siegfried Kropf, Christian Furth, Gerhard Ulrich, Ortrud Kosiek, Timm Denecke, Marianne Pavel, Andreas Pascher, Bertram Wiedenmann, Holger Amthauer, Quantification in 68Ga-DOTA(0)-Phe(1)-Tyr(3)-Octreotide Positron Emission Tomography/Computed Tomography: Can We Be Impartial about Partial Volume Effects? Neuroendocrinology. ,vol. 97, pp. 369- 374 ,(2013) , 10.1159/000350418
Thomas A. Hope, Miguel Hernandez Pampaloni, Eric Nakakura, Henry VanBrocklin, James Slater, Salma Jivan, Carina Mari Aparici, Judy Yee, Emily Bergsland, Simultaneous 68Ga-DOTA-TOC PET/MRI with gadoxetate disodium in patients with neuroendocrine tumor Abdominal Imaging. ,vol. 40, pp. 1432- 1440 ,(2015) , 10.1007/S00261-015-0409-9
Marius E. Mayerhoefer, Ahmed Ba-Ssalamah, Michael Weber, Markus Mitterhauser, Harald Eidherr, Wolfgang Wadsak, Markus Raderer, Siegfried Trattnig, Andreas Herneth, Georgios Karanikas, Gadoxetate-enhanced versus diffusion-weighted MRI for fused Ga-68-DOTANOC PET/MRI in patients with neuroendocrine tumours of the upper abdomen European Radiology. ,vol. 23, pp. 1978- 1985 ,(2013) , 10.1007/S00330-013-2785-2
Jean Claude Reubi, Jean-Claude Schär, Beatrice Waser, Sandra Wenger, Axel Heppeler, Jörg S. Schmitt, Helmut R. Mäcke, Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 27, pp. 273- 282 ,(2000) , 10.1007/S002590050034
Florian C. Gaertner, Ambros J. Beer, Michael Souvatzoglou, Matthias Eiber, Sebastian Fürst, Sybille I. Ziegler, Florian Brohl, Markus Schwaiger, Klemens Scheidhauer, Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors. Investigative Radiology. ,vol. 48, pp. 263- 272 ,(2013) , 10.1097/RLI.0B013E31828234D0
Nils Friedemann Schreiter, Ann-Mirja Bartels, Vera Froeling, Ingo Steffen, Ulrich-Frank Pape, Alexander Beck, Bernd Hamm, Winfried Brenner, Rainer Röttgen, Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT Radiology and Oncology. ,vol. 48, pp. 339- 347 ,(2014) , 10.2478/RAON-2014-0018